Release Date: 05/04/18 15:28 Summary: Variation of Takeover Bid - extension of offer period Price Sensitive: Yes Download Document 75.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%